However, other groups have reported different results: Bellini et al. [48] observed that lesion conspicuity was significantly higher in HER2-positive and triple-negative cancers compared to Luminal A tumors, suggesting that conspicuity may partly reflect tumor aggressiveness. Here, ERBB2 is linked to neoplasm.